Tinactin Jock Itch Powder Spray Recall Due to Benzene Contamination
Bayer Healthcare is recalling 592,416 cans of Tinactin (Tolnaftate 1%) Jock Itch Powder Spray distributed nationwide due to potential benzene contamination. The product was manufactured at a facility where other lots were found to be contaminated with benzene.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The FDA classified this as a Class II recall. Benzene is a known carcinogen and systemic toxicant that poses a serious health risk, particularly through inhalation from a spray product. Although no specific illness or injury reports are stated in the source text, the hazard itself—contamination with a carcinogenic substance—meets the threshold for Severe under the rubric's criteria for hazardous substances with potential for significant harm.
Plain-English summary
Bayer Healthcare Pharmaceuticals Inc. is recalling Tinactin (Tolnaftate 1%) Jock Itch Powder Spray in 133g (4.6 oz) cans. A total of 592,416 cans are affected by this recall.
The recall was initiated due to cGMP (current Good Manufacturing Practice) deviations. The product was manufactured at the same facility where other lots were found to be contaminated with benzene.
The affected product was distributed nationwide in the United States, Puerto Rico, Canada, and Mexico through a variety of retail channels. The affected lot numbers are TN00086 (CV015YU, expiration 10/31/2022), TN00273 (expiration 12/31/2022), and TN005RW (expiration 5/31/2023).
Consumers who have purchased this product should stop using it and consult their healthcare provider or pharmacist with questions.
The recalled product
- Product
- Tinactin (Tolnaftate 1%) JOCK ITCH POWDER SPRAY NET WT133g (4.6 oz) can, Dist by: Bayer Healthcare LLC, Whippany, NJ 07981, Product of Ireland 86951967, UPC 3 11017 41007 3, NDC 11523-0072-5
- Manufacturer
- Bayer Healthcare Pharmaceuticals Inc.
- Hazard
- benzene-contamination
- manufacturing-defect
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (7)
- Lot # TN00086
- CV015YU
- EXP 10/31/2022
- TN00273
- EXP 12/31/2022
- TN005RW
- Exp 5/31/2023
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- HighBeak & Skiff Alcohol Antiseptic Sanitizer recalled for acetaldehyde contamination
FDA (Drugs) · 2026-06-17
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27